Carolyn "Bo" Aldige
C3 congratulates the Prevent Cancer Foundation on their 25th anniversary this month.
We are proud of the work they do, especially in encouraging screening to prevent colorectal cancer. This March they will sponsor the 12th Dialogue for Action Prevention Hits the Headlines.
Prevent Cancer also sponsors the Super Colon Tour, an educational program accompanied by a large crawl-through colon. 2010 tour appearances are being scheduled now. Read the rest of this entry »
Being overweight was a key reason for at least 124,000 new cancers in European countries in 2008, including nearly 24,000 from colorectal cancer.
3.2 percent of new cancer diagnoses in men and 8.8 percent of women’s cancers could be attributed to excessive body mass index (BMI). This was a dramatic increase from 2002 that found 70,000 cases of cancer directly related to obesity out of 2.2 million European cancers overall. Read the rest of this entry »
Although initial reports found no reduction in polyps or cancer in people with Lynch syndrome who took aspirin and/or resistant starch supplements, longer follow-up tells a difference story.
About five years after trial participants began taking aspirin or a placebo, differences began to emerge. Even though patients in the trial only took aspirin for four years, later followup found significantly fewer colon colon cancers among those who had used aspirin, as well as fewer Lynch-related cancers overall. There were almost three times as many colon cancers in Lynch carriers who took a placebo compared to those who used aspirin. Read the rest of this entry »
The Centers for Disease Control has awarded $22 million to 26 states and tribal organizations to provide colorectal cancer screening to the uninsured and underinsured from age 50 to 64.
Through the Colorectal Cancer Control Program, five-year grants ranging from $358,283 to $1.1 million will support support screening and diagnostic follow–up care, data collection, outreach and public education, health care provider education, and program evaluation. Projects can choose from among recommended screening methods including colonoscopy, sigmoidoscopy, or stool tests.
The new funding builds on the successful CDC Colorectal Cancer Screening Demonstration Program in five sites across the US, including Baltimore, Long Island, Seattle and King County, Nebraska, and Missouri. Read the rest of this entry »
Women in Israel who used hormone replacement therapy (HRT) during and after menopause had about a 63 percent reduced risk of getting colon or rectal cancer.
However, those women who were active in sports or who took aspirin regularly didn’t benefit from HRT. Read the rest of this entry »
